Barcoded Microbeads

Each bead carries a unique molecular identifier, so signals associated with that bead can be separated from signals linked to other beads. When sequencing or another readout detects captured material, the identifier connects the molecular result to the bead that collected it. This enables many targets, cells, or measurements to be analyzed in parallel rather than treated as one combined signal.

Capture probes provide the binding interface that retains target nucleic acids on the bead surface. Once a target binds, its signal remains associated with the bead’s unique barcode, creating a link between molecular capture and bead identity. This pairing allows the assay to record which bead collected the target and supports subsequent identification through sequencing or another readout.

Tumors can contain cells or molecular populations with different biological features. Linking each captured signal to an identifiable bead helps preserve those distinctions during parallel analysis, instead of merging all measurements into a single undifferentiated result. In cancer research, that separation supports profiling heterogeneous tumor cells and comparing biomarker patterns across the material present in a sample.

After targets bind to capture probes, sequencing or another analytical readout detects both the captured molecular signal and the identifier associated with its bead. The resulting association indicates which bead generated a particular measurement. Researchers can therefore connect detected DNA, RNA, or other assay signals with the bead-level identity needed to interpret multiplexed results.

A typical workflow presents capture probes and unique identifiers on the beads, exposes them to the sample, and allows target material to bind. The assay then uses sequencing or another readout to detect the captured signals and connect them to bead identities. In cancer studies, this workflow can be applied to tumor-derived DNA, RNA, or protein measurements.

They are useful when researchers need parallel measurements from limited samples or want to examine several tumor-associated signals in one assay framework. By linking captured material to distinct bead identities, the approach can support biomarker measurement while retaining information needed to compare molecular patterns. This makes it relevant to profiling tumor material and investigating differences in treatment response.

Researchers can use bead-based multiplexed analysis to measure tumor-derived molecular signals associated with samples exposed to different treatment conditions or representing different response states. Because signals remain linked to bead identities, the resulting measurements can be compared across the analyzed material. The approach therefore helps investigate treatment responses alongside biomarker patterns and tumor-cell heterogeneity.